Insider Purchases: Inside the Buy
Tag: ContrarianStocks
Insiders Had Bought Shares of Elanco Animal Health (ELAN); Turns Out They Were Right — And It May Only Be the Beginning!
Insiders bought millions of Elanco shares under $15 — and they were right. Now, with JP Morgan’s upgrade and revenues rising, this stock might be a hidden gem in the animal health world. 🐾
Can a Tiny Insider Buy at Conagra Signal the Next Big Bull?
Conagra might not be hot sauce, but it’s finally warming up. A small insider buy, strong institutional backing, and a fat dividend yield could turn this frozen-aisle veteran into a comeback story. Just keep an eye on inflation and margins — both can melt fast.
CarMax (KMX): Where Insiders Keep Buying — And Cars Keep Driving Off (Mostly the Lot)
Insiders and institutions are revving up for CarMax’s comeback — even as used car sales slow and margins tighten. With shares 70% below their peak and a major digital overhaul underway, this could be the turnaround ride of the year. 🚘📉 Or just another trip to the mechanic.
Can Freshpet Make for a Fresh Buy: Insiders & Directors Think So
Freshpet’s stock has tumbled more than 70% from its highs, but insiders keep buying and Wall Street funds are all-in (119% ownership!). With revenue growing, profitability improving, and valuation looking much more reasonable, is this the turnaround treat investors have been waiting for? 🐾🍖
Penn Entertainment: A Double-Down That’s Finally Paying Off?
Penn Entertainment ($PENN) is showing signs of life — insiders are doubling down, revenues are climbing, and digital bets are growing fast. With shares rebounding, is it time to follow the high-rollers or step back from the table? 🎰📈
Ligand Pharmaceuticals (LGND): In a League of Its Own? Insiders Think So!
Ligand Pharma (LGND) isn’t chasing moonshots—it’s collecting royalties across a sprawling biotech empire. With both the CEO and CFO buying in, and a royalty engine showing 46% revenue growth, insiders may know something. Is this the most compelling quiet biotech turnaround on the Nasdaq?